Please assess the completion status of the following clinical trial:

Trial Title: Tetracaine Versus Lidocaine Gel for Anesthetic Effect and Comfort in Patients Undergoing LASIK

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* healthy volunteers of age 18 years or greater~Exclusion Criteria:~* Previous reaction/allergy to the same drug class~* prior ocular surgery~* active facial injuries~* any active current ophthalmological disease~* history of diabetes~* any current non- Over The Counter pain medication~* inability to complete the questionnaire.~* Economically or educationally disadvantaged persons, Prisoners, or Children~* Patients with fluctuating or impaired decision-making capacity~* Any other condition that the investigator believes would pose a significant hazard to the subject if the investigational therapy were initiated

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Tetracaine R/Lidocaine L (Type: ACTIVE_COMPARATOR): Participant's Right or Left eye will receive 0.5% Tetracaine drop, at 10 minutes and 5 minutes, prior to LASIK.
- Tetracaine L/Lidocaine R (Type: ACTIVE_COMPARATOR): Participant's Right or Left eye will receive 2% lidocaine gel, at 10 minutes and 5 minutes, prior to LASIK.

Based on this trial design, predict the completion outcome and termination type (if applicable).